TNFRSF10B and laryngeal carcinoma: In a laryngeal cancer mouse model, combined treatment with Ce6–B. bifidum–anti-DR5 Ab and sequential US and laser irradiation (Ce6–B. bifidum–anti-DR5 Ab + US→Laser) led to complete tumor regression within six days.